A piRNA chemosensitizes doxorubicin in tongue squamous cell carcinoma by targeting FDFT1 and inhibiting the EIF3H/HIF1α/CYPOR axis
Trisha Chattopadhyay, Priyajit Biswal, Sruti Biswal, Bibekanand Mallick
Topics & Concepts
Basal cellDoxorubicinTongueCancer researchChemistryTongue NeoplasmMedicineInternal medicinePathologyChemotherapyCancer-related molecular mechanisms researchRNA modifications and cancerCancer, Hypoxia, and Metabolism